Farmacosmo SpA (MIL:COSMO) Total Stockholders Equity: €5.45 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:COSMO Farmacosmo SpA MIL:COSMO
35 GF Score
Price €0.49
GF Value €0.77
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Farmacosmo SpA Total Stockholders Equity?

Farmacosmo SpA MIL:COSMO -2.02% 35 Total Stockholders Equity is €5.45 Mil as of Dec. 2025. GuruFocus rates MIL:COSMO with a GF Score™ of 35/100 and a GF Value™ of €0.77 (Possible Value Trap). The stock has 5 warning signs investors should review.

Farmacosmo SpA's Total Stockholders Equity for the quarter that ended in Dec. 2025 was €5.45 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Farmacosmo SpA's Book Value per Share for the quarter that ended in Dec. 2025 was €0.14. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Farmacosmo SpA's Debt-to-Equity for the quarter that ended in Dec. 2025 was 1.39.


Farmacosmo SpA  (MIL:COSMO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Farmacosmo SpA's Book Value per Share for the quarter that ended in Dec. 2025 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Farmacosmo SpA's Debt-to-Equity for the quarter that ended in Dec. 2025 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Farmacosmo SpA Total Stockholders Equity Related Terms


Farmacosmo SpA Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Farmacosmo SpA's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farmacosmo SpA Total Stockholders Equity Chart

Farmacosmo SpA Annual Data
Trend Dec19 Dec20 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial 0.55 17.40 12.92 10.58 5.45

Farmacosmo SpA Semi-Annual Data
Dec19 Dec20 Jun21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 12.92 12.40 10.58 7.34 5.45
MIL:COSMO
35GF Score
Farmacosmo SpA MIL:COSMO
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of €5.45 Mil mean?
Farmacosmo SpA (MIL:COSMO) has a Total Stockholders Equity of €5.45 Mil as of Dec. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Farmacosmo SpA and its competitors.
Is Farmacosmo SpA's Total Stockholders Equity too high?
Farmacosmo SpA's current Total Stockholders Equity is €5.45 Mil. Overall, Farmacosmo SpA has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Farmacosmo SpA's Total Stockholders Equity compare to competitors?
Farmacosmo SpA's Total Stockholders Equity of €5.45 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Healthcare Providers & Services company?
A good Total Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Farmacosmo SpA and its competitors. Farmacosmo SpA's current Total Stockholders Equity is €5.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farmacosmo SpA stock overvalued right now?
Based on GuruFocus' analysis, Farmacosmo SpA (MIL:COSMO) is currently considered Possible Value Trap. The stock's GF Value™ is €0.77, compared to a current price of €0.49 — trading 37% below its estimated fair value. The current Total Stockholders Equity is €5.45 Mil. Farmacosmo SpA's overall GF Score™ is 35/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Farmacosmo SpA (MIL:COSMO), the current Total Stockholders Equity is €5.45 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Farmacosmo SpA (MIL:COSMO) Overvalued in 2026?

Based on GuruFocus' analysis, Farmacosmo SpA stock appears to be undervalued. The current stock price of €0.49 is trading 37% below its estimated GF Value™ of €0.77. GuruFocus considers Farmacosmo SpA to be Possible Value Trap.

Key valuation signals for MIL:COSMO:

  • Total Stockholders Equity: €5.45 Mil
  • GF Value™: €0.77 vs. price of €0.49 (37% below fair value)
  • GF Score™: 35/100 with 5 warning signs

No single metric tells the full story. See the MIL:COSMO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Farmacosmo SpA Business Description

Address Via Crispi, Number 51, Napoli, ITA, IT-80121
Farmacosmo SpA is a wellness e-commerce company active in the Health, Pharma, and Wellness industry, authorized by the Italian Ministry of Health to sell pharmaceutical products online. In particular, the company offers parapharmaceutical products, vitamins and food supplements, dietetic products, medical devices, cosmetic products, personal hygiene products, hair care products, dental care products, skincare products, perfumes, home and baby items.
35GF Score

Get the complete analysis for MIL:COSMO

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.49
Price
€0.77
GF Value